Richard Houk, MD
Rheumatology · Little Rock, ARNPI 1497783757
Payments from drug & device makers
Across 1,344 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$6K
- AbbVie$4K
- UCB, Inc.$3K
- Johnson & Johnson$2K
- Pfizer$2K
- GSK$1K
- plus $8K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 314 | $5,648 |
| AbbVie | 205 | $3,911 |
| UCB, Inc. | 139 | $2,775 |
| Johnson & Johnson(2 entities) | 98 | $1,816 |
| Pfizer | 93 | $1,589 |
| GSK | 85 | $1,417 |
| E.r. Squibb & Sons, L.L.C. | 68 | $1,244 |
| AstraZeneca(2 entities) | 59 | $1,043 |
| Novartis | 39 | $789 |
| Mallinckrodt Hospital Products Inc. | 30 | $669 |
| Lilly USA, LLC | 42 | $637 |
| Genentech USA, Inc. | 27 | $513 |
| Organon | 23 | $350 |
| Aurinia Pharma U.S., Inc. | 16 | $341 |
| Fresenius Kabi USA, LLC | 15 | $311 |
| Pacira Therapeutics, Inc. | 10 | $258 |
| Boehringer Ingelheim | 14 | $249 |
| Merck | 13 | $194 |
| Bioventus LLC | 9 | $151 |
| Bristol Myers Squibb | 8 | $149 |
| Mallinckrodt Enterprises LLC | 7 | $125 |
| Sanofi | 5 | $84 |
| Ultragenyx Pharmaceutical Inc. | 4 | $62 |
| Pacira Pharmaceuticals Incorporated | 2 | $62 |
| Radius Health, Inc. | 2 | $56 |
| Sobi, Inc | 2 | $42 |
| ANI Pharmaceuticals, Inc. | 2 | $41 |
| Kedrion Biopharma, Inc. | 2 | $32 |
| Invivyd Inc | 2 | $29 |
| GC Biopharma USA, Inc. | 1 | $21 |
| TG Therapeutics, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
| Argenx US, Inc. | 1 | $15 |
| Sandoz | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Boston Scientific | 1 | $12 |
| Sensus Healthcare, Inc. | 1 | $0 |
How this compares
$24,710 in reported general payments places this provider in the 75th percentile of 48 rheumatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Little Rock
- Jason DareLittle Rock$194K
- Cummins LueLittle Rock$76K
- Jasen ChiLittle Rock$30K
- Columbus BrownLittle Rock$18K
- Renee Peterkin-MccalmanLittle Rock$16K
- Daniel GonzalezLittle Rock$12K
- Safwan SakrLittle Rock$11K
- Alina VoineaLittle Rock$8K
- Tamer AlsebaiLittle Rock$6K
- Mavi Rivera PavonLittle Rock$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.